Valuation : DHG Pharmaceutical

Market Cap 12,486B 481M 413M 389M 355M 662M 45.57B 666M 4.61B 1.78B 23.29B 1.81B 1.77B 74.12B P/E 2026 *
13.5x
P/E 2027 * 12.7x
Enterprise Value 10,624B 409M 352M 331M 302M 563M 38.77B 566M 3.92B 1.52B 19.82B 1.54B 1.5B 63.07B EV / Sales 2026 *
1.95x
EV / Sales 2027 * 1.87x
Free-Float
48.78%
Yield 2026 *
7.33%
Yield 2027 * 7.54%
08-21 DHG Pharma Announces Final Dividend for 2025, Payable on 30 Sep. 2026 CI
07-21 DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
07-14 Large Enterprise Tax Sub-Department Imposes Administrative Penalty on DHG Pharmaceutical Joint Stock Company CI
05-25 DHG Pharmaceutical Joint Stock Company Receives the Confirmation Certificate of Registration Changes CI
04-29 DHG Pharmaceutical Joint Stock Company Announces Adjustment of Position of Osamu Fujimori as Deputy General Director in Charge of Finance and Supply Chain, Effective May 1, 2026 CI
04-23 DHG Pharmaceutical Joint Stock Company Provides Earnings Guidance for 2026 CI
04-23 DHG Pharmaceutical Joint Stock Company Announces Board Changes, Effective April 21, 2026 CI
04-23 DHG Pharmaceutical Joint Stock Company Approves Dividend for the Fiscal Year Ended December 31, 2025, Payable on 28 May 2026 and in September 2026 CI
04-23 DHG Pharmaceutical Joint Stock Company Provides Dividend Guidance for the Fiscal Year 2026 CI
04-21 DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-26 DHG Pharmaceutical Joint Stock Company Provides Earnings Guidance for the Fiscal Year 2026 CI
01-21 DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
01-06 DHG Pharmaceutical Joint Stock Company Announces Change in Certificate of Business Registration CI
1 day-0.31%
1 week-0.10%
Current month-0.10%
1 month-0.10%
3 months+2.25%
6 months-7.46%
Current year-6.65%
1 week 95,000
Extreme 95000
96,300
1 month 93,000
Extreme 93000
96,900
Current year 89,900
Extreme 89900
109,000
1 year 89,900
Extreme 89900
110,000
3 years 87,000
Extreme 87000
125,900
5 years 78,000
Extreme 78000
142,500
10 years 61,000
Extreme 60999.999999
142,500
Manager TitleAgeSince
Chief Executive Officer 59 -
Director of Finance/CFO - -
Chief Executive Officer 52 01/09/2017
Director TitleAgeSince
Director/Board Member 52 01/03/2000
Director/Board Member 70 15/08/2016
Chairman - 11/06/2019
Date Insider Type Main position Quantity % Market Cap. Importance
26/5/22 Buy

Chief Financial Officer

18,700 0.0143%
Change 5-day change 1-year change 3-year change Capi.($)
-0.31%-0.10%-6.83%-22.67% 481M
-2.21%-3.11%+52.16%+91.64% 1,024B
-2.22%-0.76%+51.08%+67.61% 663B
-2.99%-4.31%+18.59%+66.94% 453B
-0.88%-0.65%+27.83%+36.57% 349B
-10.89%-9.30%+7.52%+26.14% 295B
-1.38%-0.79%-1.77%+9.72% 253B
-10.08%-10.26%+40.32%+51.55% 236B
-2.32%-0.14%-16.57%-56.82% 206B
-2.88%-2.19%+26.54%+92.95% 187B
Average -3.48%+1.04%+19.89%+36.36% 366.78B
Weighted average by Cap. -3.22%+0.52%+32.26%+57.23%

Financials

2026 *2027 *
Net sales 5,435B 209M 180M 169M 154M 288M 19.84B 290M 2.01B 776M 10.14B 786M 769M 32.26B 5,691B 219M 188M 177M 162M 302M 20.77B 303M 2.1B 812M 10.62B 823M 805M 33.78B
Net income 928B 35.74M 30.73M 28.91M 26.38M 49.24M 3.39B 49.49M 343M 133M 1.73B 134M 131M 5.51B 983B 37.86M 32.55M 30.62M 27.95M 52.15M 3.59B 52.42M 363M 140M 1.83B 142M 139M 5.84B
Net Debt -1,862B -71.7M -61.65M -58M -52.93M -98.78M -6.8B -99.29M -687M -266M -3.47B -269M -263M -11.06B -1,858B -71.52M -61.5M -57.85M -52.8M -98.53M -6.78B -99.04M -685M -265M -3.47B -269M -263M -11.03B
Logo DHG Pharmaceutical
DHG Pharmaceutical Joint Stock Company is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures and markets pharmaceutical products, vitamins, supplements and cosmetics. Via its subsidiaries, the Company is also involved in packaging printing, herb cultivation, medicinal supplies trading, as well as domestic travel tour and medical clinic operation.
Employees
2,805
Date Price Change Volume
08/09/26 95,500.00 -0.31% 7,399
07/09/26 ₫95,800.00 +0.21% 6,163
04/09/26 ₫95,600.00 -0.31% 7,268
Trader
-
Investor
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
95,500.00VND
Average target price
97,600.00VND
Spread / Average Target
+2.20%

Annual profits - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!